Billions of dollars in opioid settlement money are flowing into states across the country to combat drug addiction, prevent overdoses and save lives, but a new investigation is raising questions about how that money is being spent and whether taxpayer-funded programs are delivering measurable results.<\/p>\n
The funding comes from major legal settlements involving opioid manufacturers, distributors and other companies accused of contributing to the nation’s opioid epidemic.<\/p>\n
States and local governments are receiving billions of dollars intended to expand addiction treatment, support prevention programs, distribute overdose-reversal medications and help communities recover from years of devastating drug-related deaths.<\/p>\n
But government transparency watchdog Open the Books says some states are failing to provide enough information to determine whether those investments are actually reducing overdoses.<\/p>\n
Rachel O’Brien, deputy public policy editor at Open the Books, joined The National News Desk to discuss her organization’s investigation into opioid settlement spending, with a particular focus on Pennsylvania and other states hit hard by the epidemic.<\/p>\n
“So far, Pennsylvania’s got $2 billion,” O’Brien said. “They’re getting another $212 million this year from that large Purdue Pharma Sackler family settlement.”<\/p>\n
The settlement involving Purdue Pharma and the Sackler family is part of a broader effort to hold companies accountable for their alleged roles in fueling the opioid crisis.<\/p>\n
The money is intended to support programs that address substance use disorders, reduce overdose deaths and expand access to treatment and recovery services.<\/p>\n
O’Brien said Pennsylvania has spent less than $84 million on certain opioid-related programs examined in her organization’s investigation, including prevention, education, treatment and harm reduction efforts.<\/p>\n
“They’ve spent less than $84 million of it on prevention and education, including for people behind bars, on treatment, on harm reduction supplies like Narcan if someone’s having an overdose, fentanyl testing strips and more,” O’Brien said.<\/p>\n
Naloxone, commonly sold under the brand name Narcan, can reverse an opioid overdose when administered quickly. Fentanyl test strips can help identify the presence of fentanyl in certain substances, potentially reducing the risk of accidental exposure.<\/p>\n
O’Brien said the issue is not necessarily whether those programs serve a legitimate purpose, but whether states are collecting enough information to determine which efforts are most effective.<\/p>\n
“We wanted to see where they’ve only spent $84 million so far, which is actually a lot, right?” O’Brien said.<\/p>\n
“They’ve got a lot more coming that they’re going to spend. We want to know what’s working and what’s not working.”<\/p>\n
According to O’Brien, her organization found that publicly available information often identifies broad spending categories without providing clear evidence of how individual programs are affecting overdose deaths.<\/p>\n
“That information is not out there,” O’Brien said.<\/p>\n
The investigation focused on Pennsylvania, West Virginia and Ohio, three states in the Rust Belt that have experienced significant harm from opioid addiction and overdose deaths.<\/p>\n
O’Brien said the organization encountered similar transparency concerns across the states it examined.<\/p>\n
“Other Rust Belt states we looked at include West Virginia and Ohio,” O’Brien said. “They also don’t release any sort of performance data on whether this money is effective.”<\/p>\n
To better understand the relationship between spending and outcomes, Open the Books compared opioid settlement expenditures with overdose death data across Pennsylvania counties.<\/p>\n
O’Brien said researchers examined how much counties spent and whether higher spending appeared to correspond with fewer overdose deaths.<\/p>\n
“We looked at the overdose deaths by county in Pennsylvania and the amount spent by each county and found no correlation between spending and deaths,” O’Brien said.<\/p>\n
The organization examined information from 51 of Pennsylvania’s 67 counties that provided spending data.<\/p>\n
O’Brien highlighted the wide variation in how much counties spent relative to the number of overdose deaths.<\/p>\n
“We found it didn’t matter if the county spent $714 for every overdose death, like in Lackawanna County, or if they spent over $42,000 for every overdose death in Delaware County,” O’Brien said.<\/p>\n
“There was no pattern in the outcomes.”<\/p>\n
The findings raise questions about whether states and counties have established adequate systems for tracking the effectiveness of settlement-funded programs.<\/p>\n
However, a lack of correlation between spending and overdose deaths does not necessarily establish that the programs are ineffective.<\/p>\n
Overdose deaths can be influenced by numerous factors, including drug supply changes, access to treatment, population differences, local health conditions and the amount of time needed for prevention programs to produce results.<\/p>\n
Communities experiencing more severe addiction problems may also receive more funding, making direct comparisons between spending and overdose deaths difficult without accounting for those differences.<\/p>\n
O’Brien said the larger problem is that state officials have not provided enough detailed information for the public to evaluate those factors.<\/p>\n
According to the investigation, Pennsylvania’s opioid settlement administrator reported spending approximately $22 million on prevention and education, $15 million on treatment and $18.5 million on programs involving incarcerated individuals.<\/p>\n
“The statewide fund that administers this money says they spent $22 million on prevention and education, $15 million on treatment, and another $18.5 million for programs for people behind bars,” O’Brien said.<\/p>\n
But she argued that those categories are too broad to show taxpayers exactly what they are funding or whether specific initiatives are achieving their goals.<\/p>\n
“These are vague categories,” O’Brien said. “They don’t give specifics, and we still don’t know if it’s working.”<\/p>\n
The issue is especially significant because opioid settlement agreements are expected to provide funding over multiple years, giving states an opportunity to build long-term addiction prevention and treatment programs.<\/p>\n
Supporters of the settlements argue that sustained investment is necessary because the opioid epidemic developed over decades and cannot be reversed through short-term interventions alone.<\/p>\n
O’Brien said that makes performance tracking even more important.<\/p>\n
The interview then turned to who is responsible for overseeing the spending and whether states should be required to conduct regular audits.<\/p>\n
O’Brien argued that opioid settlement money should receive the same financial scrutiny as other major government funding programs.<\/p>\n
“No one’s holding them accountable,” O’Brien said.<\/p>\n
“So they should be doing their own audits just like they do with other spending.”<\/p>\n
She pointed to Pennsylvania’s oversight of tobacco settlement funds as an example of how the state could approach opioid settlement spending.<\/p>\n
“Pennsylvania’s auditor general has audited the state’s tobacco settlement spending every year,” O’Brien said.<\/p>\n
“But he hasn’t audited the opioid settlement.”<\/p>\n
O’Brien said independent audits could help determine whether money is reaching the intended programs, whether spending complies with settlement requirements and whether funded initiatives are producing measurable benefits.<\/p>\n
“Audits need to happen,” O’Brien said. “We need to see if the money is being spent well.”<\/p>\n
She also raised concerns about public access to financial records from the trust responsible for administering Pennsylvania’s opioid settlement funding.<\/p>\n
“The trust that decides how to spend this money isn’t subject to open records laws,” O’Brien said.<\/p>\n
She explained that much of the information her organization reviewed was made available voluntarily rather than through detailed mandatory disclosure requirements.<\/p>\n
“The way we got these big categories of how the money was spent was because, like many states, they volunteer it,” O’Brien said.<\/p>\n
“But they’re not required to go beyond large chunks of money buckets without specifics.”<\/p>\n
That lack of detail, she argued, makes it harder for taxpayers, journalists and policymakers to determine which programs deserve continued funding.<\/p>\n
O’Brien said states should establish clearer reporting requirements that identify specific projects, document how much each receives and measure outcomes over time.<\/p>\n
Such measures could include tracking the number of people receiving addiction treatment, access to overdose-reversal medications, treatment retention rates and changes in overdose deaths.<\/p>\n
Public health researchers generally caution that measuring the effectiveness of opioid programs requires more than examining annual overdose death totals because prevention and treatment efforts may produce benefits over several years.<\/p>\n
Still, O’Brien argued that states should be able to demonstrate whether their spending strategies are working and make adjustments when the evidence suggests they are not.<\/p>\n
“Before they get more money, the state should know for their own benefit, for the people this is supposed to benefit, if it’s working and change course if it’s not,” O’Brien said.<\/p>\n
The investigation comes as communities continue grappling with the long-term consequences of opioid addiction, including fatal overdoses, family disruption and pressure on health care and emergency response systems.<\/p>\n
With billions more in settlement funding expected to be distributed, questions about oversight and accountability are becoming increasingly important.<\/p>\n
O’Brien said the goal should be ensuring that money intended to address the opioid crisis is being directed toward programs that can demonstrate meaningful results.<\/p>\n
“We want to know what’s working and what’s not working,” O’Brien said.<\/p>\n
For Open the Books, the findings underscore the need for stronger financial oversight, greater transparency and clearer measures of success before states commit additional settlement funds.<\/p>\n
“Audits need to happen,” O’Brien said. “We need to see if the money is being spent well.”<\/p>\n","protected":false},"excerpt":{"rendered":"Billions of dollars in opioid settlement money are flowing into states across the country to combat drug addiction,…\n","protected":false},"author":2,"featured_media":312885,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[28,30,29],"class_list":["post-312884","post","type-post","status-publish","format-standard","has-post-thumbnail","category-pennsylvania","tag-pennsylvania","tag-pennsylvania-headlines","tag-pennsylvania-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/posts\/312884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/comments?post=312884"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/posts\/312884\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/media\/312885"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/media?parent=312884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/categories?post=312884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-pa\/wp-json\/wp\/v2\/tags?post=312884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}